Compare SNAP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNAP | ICLR |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 8.2B |
| IPO Year | 2017 | 2001 |
| Metric | SNAP | ICLR |
|---|---|---|
| Price | $6.02 | $116.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 26 | 13 |
| Target Price | $8.41 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 54.3M | 1.1M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $824,949,000.00 | N/A |
| Revenue This Year | $15.55 | N/A |
| Revenue Next Year | $9.82 | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | ★ 103.95 | N/A |
| 52 Week Low | $3.81 | $66.57 |
| 52 Week High | $10.41 | $211.00 |
| Indicator | SNAP | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 61.12 | 57.41 |
| Support Level | $4.65 | $102.53 |
| Resistance Level | $7.62 | $121.03 |
| Average True Range (ATR) | 0.31 | 5.07 |
| MACD | 0.05 | -0.23 |
| Stochastic Oscillator | 85.72 | 81.80 |
Snap is a technology company best known for its marquis social media application. Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.